SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
TLD and HIV Treatment in LMIC: What Are We Learning?
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
2 of
2
|
Validity of Point-of-Care Urine Tenofovir Testing to Differentiate Viremia Versus Suppression on TLD (ABSTRACT
508)
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
Short Text Messages Improve Antiretroviral Adherence Among People Living With HIV in Georgia (ABSTRACT
509)
Otar Chokoshvili
T. Tsertsvadze Infectious Diseases AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
2 of
2
|
